Paul E. Zarek

Array ( [id] => 4728124 [patent_doc_number] => 20080207668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF HYDROMORPHONE FOR PREVENTION OF OVERDOSE OR ABUSE' [patent_app_type] => utility [patent_app_number] => 11/868283 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11776 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207668.pdf [firstpage_image] =>[orig_patent_app_number] => 11868283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904488 [patent_doc_number] => 20080113902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of ramoplanin to treat diseases associated with the use of antibiotics' [patent_app_type] => utility [patent_app_number] => 11/906750 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7159 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113902.pdf [firstpage_image] =>[orig_patent_app_number] => 11906750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494541 [patent_doc_number] => 20100093755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Ketoconazole Enantiomer in Humans' [patent_app_type] => utility [patent_app_number] => 12/443531 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7390 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093755.pdf [firstpage_image] =>[orig_patent_app_number] => 12443531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327664 [patent_doc_number] => 20100197685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/443972 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 37756 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197685.pdf [firstpage_image] =>[orig_patent_app_number] => 12443972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311838 [patent_doc_number] => 08653056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation' [patent_app_type] => utility [patent_app_number] => 12/443304 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 12158 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12443304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4508290 [patent_doc_number] => 07915304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT' [patent_app_type] => utility [patent_app_number] => 12/444407 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 13760 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915304.pdf [firstpage_image] =>[orig_patent_app_number] => 12444407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558871 [patent_doc_number] => 20090270448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL' [patent_app_type] => utility [patent_app_number] => 12/441501 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4707 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270448.pdf [firstpage_image] =>[orig_patent_app_number] => 12441501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629759 [patent_doc_number] => 20100004294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Stable Lozenge Compositions Providing Rapid Release of Nicotine' [patent_app_type] => utility [patent_app_number] => 12/226273 [patent_app_country] => US [patent_app_date] => 2007-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7325 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004294.pdf [firstpage_image] =>[orig_patent_app_number] => 12226273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114843 [patent_doc_number] => 08158638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Pyrazolopyrimidine derivative' [patent_app_type] => utility [patent_app_number] => 12/442094 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73183 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158638.pdf [firstpage_image] =>[orig_patent_app_number] => 12442094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398417 [patent_doc_number] => 20090318480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'METHOD FOR TREATING CANCER HARBORING EGFR MUTATIONS' [patent_app_type] => utility [patent_app_number] => 12/441180 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9977 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318480.pdf [firstpage_image] =>[orig_patent_app_number] => 12441180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398492 [patent_doc_number] => 20090318555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Treatment of Vertigo with Acetyl-L-Leucine' [patent_app_type] => utility [patent_app_number] => 12/310908 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3275 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318555.pdf [firstpage_image] =>[orig_patent_app_number] => 12310908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495880 [patent_doc_number] => 20100010039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'POLYMORPHIC CRYSTAL FORM OF A INDAN-2-YLAMINO-HYDROXYETHYL-QUINOLINONE MALEATE DERIVATIVE AS BETA-ADRENOCEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 12/438407 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5646 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010039.pdf [firstpage_image] =>[orig_patent_app_number] => 12438407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629598 [patent_doc_number] => 08008492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions' [patent_app_type] => utility [patent_app_number] => 12/439490 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11297 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008492.pdf [firstpage_image] =>[orig_patent_app_number] => 12439490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445292 [patent_doc_number] => 20100144708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/376889 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17041 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144708.pdf [firstpage_image] =>[orig_patent_app_number] => 12376889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545344 [patent_doc_number] => 20100016300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Imidazoacridine Compounds for Treating FLT3-Mediated Disorders' [patent_app_type] => utility [patent_app_number] => 12/375997 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16747 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016300.pdf [firstpage_image] =>[orig_patent_app_number] => 12375997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495735 [patent_doc_number] => 20100010028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'USE OF POLYOLS TO OBTAIN STABLE POLYMORPHOUS FORMS OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 12/439094 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3944 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010028.pdf [firstpage_image] =>[orig_patent_app_number] => 12439094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249238 [patent_doc_number] => 20100137344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'INDUCTION OF ANALGESIA IN NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 12/375627 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16218 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137344.pdf [firstpage_image] =>[orig_patent_app_number] => 12375627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374757 [patent_doc_number] => 20090312318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'THERAPEUTIC COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/307634 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14933 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312318.pdf [firstpage_image] =>[orig_patent_app_number] => 12307634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496502 [patent_doc_number] => 20100010077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'PROCESS FOR THE ADDITIVATION OF WINE' [patent_app_type] => utility [patent_app_number] => 12/374714 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3880 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010077.pdf [firstpage_image] =>[orig_patent_app_number] => 12374714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257585 [patent_doc_number] => 20100029682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME' [patent_app_type] => utility [patent_app_number] => 12/374088 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22925 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029682.pdf [firstpage_image] =>[orig_patent_app_number] => 12374088 [rel_patent_id] =>[rel_patent_doc_number] =>)